THE EFFECTIVE USE OF BEZAFIBRATE AS A SECOND LINE THERAPY FOR PRIMARY BILIARY CHOLANGITIS

被引:0
|
作者
Howden, Adam [1 ]
Valliani, Talal [1 ]
机构
[1] North Bristol NHS Trust Liver Unit, Bristol, Avon, England
关键词
D O I
10.1136/gutjnl-2021-BASL.32
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P023
引用
收藏
页码:A21 / A22
页数:2
相关论文
共 50 条
  • [1] THE EFFECTIVE USE OF BEZAFIBRATE AS A SECOND LINE THERAPY FOR PBC
    Valliani, Talal
    Howden, Adam
    HEPATOLOGY, 2021, 74 : 785A - 785A
  • [2] BEZAFIBRATE AS SECOND LINE TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: A REAL WORLD EXPERIENCE
    McCabe, Rebecca
    Prince, Martin
    Greer, Shaun
    Dhaliwal, Harpreet
    GUT, 2021, 70 : A147 - A147
  • [3] Bezafibrate in Primary Biliary Cholangitis
    Jones, David E.
    Hegade, Vinod S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (10): : 984 - 984
  • [4] Bezafibrate for primary biliary cholangitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (08): : 533 - 533
  • [5] Bezafibrate for primary biliary Cholangitis "Bezafibrate in combination with ursodeoxycholic acid in primary biliary cholangitis (BEZURSO) trial"
    Klose, G.
    Nitschmann, S.
    INTERNIST, 2018, 59 (12): : 1344 - 1346
  • [6] Bezafibrate in Primary Biliary Cholangitis REPLY
    Corpechot, Christophe
    Chazouilleres, Olivier
    Rousseau, Alexandra
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (10): : 985 - 985
  • [9] Advancing Second-Line Treatment for Primary Biliary Cholangitis
    Assis, David N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [10] Time to initiation of the second-line therapy obeticholic acid in patients with primary biliary cholangitis
    Kumar, Sonal
    MacEwan, Joanna P.
    Levine, Alina
    Bessonova, Leona
    Nair, Radhika
    Wheeler, Darren
    Li, Jing
    Brown, Robert S., Jr.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S314 - S315